Contrast‐enhancing computed tomography ring in glioblastoma multiforme after intraoperative endocurietherapy

P. P. Kumar, R. R. Good, E. O. Jones, F. M. Skultety, L. G. Leibrock, Rodney D McComb

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The significance of the contrast‐enhancing ring seen on serial follow‐up postirradiation computed tomograms (CT) of the brain was evaluated in a group of 41 patients with glioblastoma multiforme (GM) who were treated in a phase I/II study by means of intraoperative remote afterloading endocurietherapy (ECT) with a high activity cobalt 60 probe (20.00 Gy) in one high‐dose rate fraction), and conventional fractionated external‐beam (EXRT) radiotherapy (60.00 Gy in 30 fractions in 7.5 weeks). All received minimum total tumor doses of 80.00 Gy. After completion of treatment, all patients were followed with serial CT scans of the brain. Two to 6 months after treatment, 27 of 41 patients developed the similar thin‐walled, regular, contrast‐enhancing CT rings with low‐density attenuation inside and outside the ring. Postmortem study in two of these patients revealed that the thin‐walled, regular, contrast‐enhancing ring represented a continuous capsule of dilated cerebral vessels with inner low‐density attenuation corresponding to necrosis, and outer low‐density attenuation corresponding to edema. The CT appearance of the thin‐walled, regular, contrast‐enhancing ring produced after high‐dose rate intraoperative ECT and EXRT is distinctly different from the CT ring characteristic of untreated or recurrent GM. After high‐dose rate intracranial ECT and EXRT, the appearance of a post‐ECT contrast‐enhancing CT ring should not be automatically interpreted as recurrent disease as previously reported after conventional fractionated EXRT.

Original languageEnglish (US)
Pages (from-to)1759-1765
Number of pages7
JournalCancer
Volume61
Issue number9
DOIs
StatePublished - May 1 1988

Fingerprint

Glioblastoma
Tomography
Brain
Cobalt
Capsules
Edema
Necrosis
Radiotherapy
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Contrast‐enhancing computed tomography ring in glioblastoma multiforme after intraoperative endocurietherapy. / Kumar, P. P.; Good, R. R.; Jones, E. O.; Skultety, F. M.; Leibrock, L. G.; McComb, Rodney D.

In: Cancer, Vol. 61, No. 9, 01.05.1988, p. 1759-1765.

Research output: Contribution to journalArticle

Kumar, P. P. ; Good, R. R. ; Jones, E. O. ; Skultety, F. M. ; Leibrock, L. G. ; McComb, Rodney D. / Contrast‐enhancing computed tomography ring in glioblastoma multiforme after intraoperative endocurietherapy. In: Cancer. 1988 ; Vol. 61, No. 9. pp. 1759-1765.
@article{35cbb78dc11b4418aef106195b160dde,
title = "Contrast‐enhancing computed tomography ring in glioblastoma multiforme after intraoperative endocurietherapy",
abstract = "The significance of the contrast‐enhancing ring seen on serial follow‐up postirradiation computed tomograms (CT) of the brain was evaluated in a group of 41 patients with glioblastoma multiforme (GM) who were treated in a phase I/II study by means of intraoperative remote afterloading endocurietherapy (ECT) with a high activity cobalt 60 probe (20.00 Gy) in one high‐dose rate fraction), and conventional fractionated external‐beam (EXRT) radiotherapy (60.00 Gy in 30 fractions in 7.5 weeks). All received minimum total tumor doses of 80.00 Gy. After completion of treatment, all patients were followed with serial CT scans of the brain. Two to 6 months after treatment, 27 of 41 patients developed the similar thin‐walled, regular, contrast‐enhancing CT rings with low‐density attenuation inside and outside the ring. Postmortem study in two of these patients revealed that the thin‐walled, regular, contrast‐enhancing ring represented a continuous capsule of dilated cerebral vessels with inner low‐density attenuation corresponding to necrosis, and outer low‐density attenuation corresponding to edema. The CT appearance of the thin‐walled, regular, contrast‐enhancing ring produced after high‐dose rate intraoperative ECT and EXRT is distinctly different from the CT ring characteristic of untreated or recurrent GM. After high‐dose rate intracranial ECT and EXRT, the appearance of a post‐ECT contrast‐enhancing CT ring should not be automatically interpreted as recurrent disease as previously reported after conventional fractionated EXRT.",
author = "Kumar, {P. P.} and Good, {R. R.} and Jones, {E. O.} and Skultety, {F. M.} and Leibrock, {L. G.} and McComb, {Rodney D}",
year = "1988",
month = "5",
day = "1",
doi = "10.1002/1097-0142(19880501)61:9<1759::AID-CNCR2820610907>3.0.CO;2-6",
language = "English (US)",
volume = "61",
pages = "1759--1765",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Contrast‐enhancing computed tomography ring in glioblastoma multiforme after intraoperative endocurietherapy

AU - Kumar, P. P.

AU - Good, R. R.

AU - Jones, E. O.

AU - Skultety, F. M.

AU - Leibrock, L. G.

AU - McComb, Rodney D

PY - 1988/5/1

Y1 - 1988/5/1

N2 - The significance of the contrast‐enhancing ring seen on serial follow‐up postirradiation computed tomograms (CT) of the brain was evaluated in a group of 41 patients with glioblastoma multiforme (GM) who were treated in a phase I/II study by means of intraoperative remote afterloading endocurietherapy (ECT) with a high activity cobalt 60 probe (20.00 Gy) in one high‐dose rate fraction), and conventional fractionated external‐beam (EXRT) radiotherapy (60.00 Gy in 30 fractions in 7.5 weeks). All received minimum total tumor doses of 80.00 Gy. After completion of treatment, all patients were followed with serial CT scans of the brain. Two to 6 months after treatment, 27 of 41 patients developed the similar thin‐walled, regular, contrast‐enhancing CT rings with low‐density attenuation inside and outside the ring. Postmortem study in two of these patients revealed that the thin‐walled, regular, contrast‐enhancing ring represented a continuous capsule of dilated cerebral vessels with inner low‐density attenuation corresponding to necrosis, and outer low‐density attenuation corresponding to edema. The CT appearance of the thin‐walled, regular, contrast‐enhancing ring produced after high‐dose rate intraoperative ECT and EXRT is distinctly different from the CT ring characteristic of untreated or recurrent GM. After high‐dose rate intracranial ECT and EXRT, the appearance of a post‐ECT contrast‐enhancing CT ring should not be automatically interpreted as recurrent disease as previously reported after conventional fractionated EXRT.

AB - The significance of the contrast‐enhancing ring seen on serial follow‐up postirradiation computed tomograms (CT) of the brain was evaluated in a group of 41 patients with glioblastoma multiforme (GM) who were treated in a phase I/II study by means of intraoperative remote afterloading endocurietherapy (ECT) with a high activity cobalt 60 probe (20.00 Gy) in one high‐dose rate fraction), and conventional fractionated external‐beam (EXRT) radiotherapy (60.00 Gy in 30 fractions in 7.5 weeks). All received minimum total tumor doses of 80.00 Gy. After completion of treatment, all patients were followed with serial CT scans of the brain. Two to 6 months after treatment, 27 of 41 patients developed the similar thin‐walled, regular, contrast‐enhancing CT rings with low‐density attenuation inside and outside the ring. Postmortem study in two of these patients revealed that the thin‐walled, regular, contrast‐enhancing ring represented a continuous capsule of dilated cerebral vessels with inner low‐density attenuation corresponding to necrosis, and outer low‐density attenuation corresponding to edema. The CT appearance of the thin‐walled, regular, contrast‐enhancing ring produced after high‐dose rate intraoperative ECT and EXRT is distinctly different from the CT ring characteristic of untreated or recurrent GM. After high‐dose rate intracranial ECT and EXRT, the appearance of a post‐ECT contrast‐enhancing CT ring should not be automatically interpreted as recurrent disease as previously reported after conventional fractionated EXRT.

UR - http://www.scopus.com/inward/record.url?scp=0023926094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023926094&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19880501)61:9<1759::AID-CNCR2820610907>3.0.CO;2-6

DO - 10.1002/1097-0142(19880501)61:9<1759::AID-CNCR2820610907>3.0.CO;2-6

M3 - Article

C2 - 2833338

AN - SCOPUS:0023926094

VL - 61

SP - 1759

EP - 1765

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 9

ER -